The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review
AP Risselada, MF Looije, AA Kruize… - Seminars in arthritis and …, 2013 - Elsevier
OBJECTIVES: To determine whether the presence of germinal centers (GCs) in salivary
glands of patients with primary Sjögren's syndrome (pSS) is related to the severity of disease …
glands of patients with primary Sjögren's syndrome (pSS) is related to the severity of disease …
Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations
P Brito-Zerón, E Theander, C Baldini… - Expert review of …, 2016 - Taylor & Francis
Sjögren's syndrome (SjS) is a systemic autoimmune disease that mainly affects the exocrine
glands, leading to generalized mucosal dryness. However, primary SjS may initially present …
glands, leading to generalized mucosal dryness. However, primary SjS may initially present …
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's …
P Brito-Zerón, S Retamozo, B Kostov, C Baldini… - RMD open, 2019 - rmdopen.bmj.com
Objective To evaluate current evidence on the efficacy and safety of topical and systemic
medications in patients with primary Sjögren syndrome (SjS) to inform European League …
medications in patients with primary Sjögren syndrome (SjS) to inform European League …
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
R Seror, P Ravaud, X Mariette, H Bootsma… - Annals of the …, 2011 - ard.bmj.com
Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain …
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain …
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
M Ramos-Casals, P Brito-Zerón… - Annals of the …, 2020 - ard.bmj.com
The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in
recent decades: treatment decisions remain challenging in clinical practice, without a …
recent decades: treatment decisions remain challenging in clinical practice, without a …
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity …
Objectives To define disease activity levels, minimal clinically important improvement (MCII)
and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) …
and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) …
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
R Seror, E Theander, JG Brun… - Annals of the …, 2015 - ard.bmj.com
Objectives To validate the two recently developed disease activity indexes for assessment of
primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) SS …
primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) SS …
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big …
Objectives To analyse the influence of geolocation and ethnicity on the clinical presentation
of primary Sjögren's syndrome (SjS) at diagnosis. Methods The Big Data Sjögren Project …
of primary Sjögren's syndrome (SjS) at diagnosis. Methods The Big Data Sjögren Project …
How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)
Objective. To evaluate the influence of the main immunological markers on the disease
phenotype at diagnosis in a large international cohort of patients with primary Sjogren's …
phenotype at diagnosis in a large international cohort of patients with primary Sjogren's …
The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome
AP Risselada, AA Kruize, R Goldschmeding… - Annals of the …, 2014 - ard.bmj.com
Objectives To investigate the prognostic value of the lymphocytic focus score (LFS) and the
percentages of IgA+, IgM+ and IgG+ plasma cells for disease severity of primary Sjögren …
percentages of IgA+, IgM+ and IgG+ plasma cells for disease severity of primary Sjögren …